Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacological reactivation of p53 as a strategy to treat cancer.

Journal of internal medicine - 1 Feb 2015

Zawacka-Pankau J, Selivanova G

Abstract excerpt

It has been confirmed through studies using the technique of unbiased sequencing that the TP53 tumour suppressor is the most frequently inactivated gene in cancer. This finding, together with results from earlier studies, provides compelling evidence for the idea that p53 ablation is required for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Clinical Trials, Phase II as Topic
Share to Evidence-Based Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Targeted Therapy

Share to Mutation, Missense

Share to Neoplasms

Share to Proto-Oncogene Proteins c-mdm2

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 25495071
DOI: 10.1111/joim.12336

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Prepared record publication-25495071-2026-09-05.1. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacological reactivation of p53 as a strategy to treat cancer.PMID 25495071Read ↗

Mutant p53 reactivation by small molecules makes its way to the clinic.Semantic proximity Read ↗

Pharmacological reactivation of mutant p53: from protein structure to the cancer patient.Semantic proximity Read ↗

Targeting mutant p53 for efficient cancer therapy.Semantic proximity Read ↗

Salvation of the fallen angel: Reactivating mutant p53Semantic proximity Read ↗

Chemical Variations on the p53 Reactivation ThemeSemantic proximity Read ↗

Pharmacological activation of p53 in cancer cells.Semantic proximity Read ↗

Pharmacological targeting of mutant p53Semantic proximity Read ↗

Restoration of wild‐type p53 function in human cancer: Relevance for tumor therapySemantic proximity Read ↗

Translating p53-based therapies for cancer into the clinic.Semantic proximity Read ↗

Targeting of Mutant p53 and the Cellular Redox Balance by APR-246 as a Strategy for Efficient Cancer TherapySemantic proximity Read ↗

The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches.Semantic proximity Read ↗

New therapeutic strategies to treat human cancers expressing mutant p53 proteins.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.